1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 08 FEBRUARY 2016

Cancer Drug News 08 FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Oncology Performance Validates Strong Focus
Industry Brief - Immunomedics' Sacituzumab Govitecan Gains FDA Breakthrough Therapy Designation For TNBC
Industry Trend Analysis - Direct Jakafi Competition Prospects In Myelofibrosis Waning
Industry Brief - Seattle Receives Adcetris Milestone Payment From Takeda
Industry Brief - ST Asia To Distribute PharmaMar's Aplidin In Asia-Pacific
Industry Brief - OSE Pharma Initiates US Phase III Study Of Tedopi In NSCLC
Industry Brief - Tagrisso Approved In EU
Industry Brief - ImmunoGen/Merck Enter Clinical Research Collaboration In OC
Industry Brief - TapImmune Granted Fast Track Designation For Lead Cancer Vaccine
Industry Brief - Opdivo Phase III SCCHN Trial Stopped Early Following Favourable Results
Industry Brief - MedinCell/Sandoz Collaborate To Develop Long-Acting Injectable Products
Industry Trend Analysis - GSK Making Gains In Customising Novel Oncology Division
Industry Brief - Mersana/Takeda Expand ACD Partnership
Industry Brief - Eagle Launches Alcohol-Free Docetaxel
Industry Brief - AstraZeneca Completes Majority Equity Stake Purchase Of Acerta
Industry Trend Analysis - NGS Portfolio Development To Benefit Diagnostics And Pharmaceuticals

Table Of Contents

Cancer Drug News 08 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.